Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

23andMe denies "designer babies" plan

This article was originally published in Clinica

Executive Summary

It sounds like something out of a sci-fi movie: consumer genetic testing specialist has been caught up in a row over a patent that covers a product that some say could allow the creation of “designer babies.” The company has denied that it intends to apply the product for this use, but this has not stopped commentators weighing in on whether this would be ethical or even scientifically plausible.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT100931

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel